Novavax CEO Buys 83,333 Shares as Insider Activity Signals Confidence in Rising Biopharma Future
Novavax insider buys signal confidence in a rising vaccine firm, hinting at future upside amid strong market gains and strategic growth plans.
4 minutes to read